Transdermal Drug Delivery System Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4094648
- 115 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Transdermal Drug Delivery System market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Transdermal Drug Delivery System market segmented into
OTC
Nitroglycerin
Estradiol
Nicotine
Others
Based on the end-use, the global Transdermal Drug Delivery System market classified into
OTC
Rx
Based on geography, the global Transdermal Drug Delivery System market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM INDUSTRY
2.1 Summary about Transdermal Drug Delivery System Industry
2.2 Transdermal Drug Delivery System Market Trends
2.2.1 Transdermal Drug Delivery System Production & Consumption Trends
2.2.2 Transdermal Drug Delivery System Demand Structure Trends
2.3 Transdermal Drug Delivery System Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Fentanyl
4.2.2 Nitroglycerin
4.2.3 Estradiol
4.2.4 Nicotine
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 OTC
4.3.2 Rx
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Fentanyl
5.2.2 Nitroglycerin
5.2.3 Estradiol
5.2.4 Nicotine
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 OTC
5.3.2 Rx
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Fentanyl
6.2.2 Nitroglycerin
6.2.3 Estradiol
6.2.4 Nicotine
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 OTC
6.3.2 Rx
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Fentanyl
7.2.2 Nitroglycerin
7.2.3 Estradiol
7.2.4 Nicotine
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 OTC
7.3.2 Rx
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Fentanyl
8.2.2 Nitroglycerin
8.2.3 Estradiol
8.2.4 Nicotine
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 OTC
8.3.2 Rx
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Fentanyl
9.2.2 Nitroglycerin
9.2.3 Estradiol
9.2.4 Nicotine
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 OTC
9.3.2 Rx
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Hisamitsu
10.1.2 Mylan
10.1.3 GSK
10.1.4 Novartis
10.1.5 Teve (Actavis)
10.1.6 Johnson & Johnson
10.1.7 Lohmann
10.1.8 Teikoku Seiyaku
10.1.9 Bayer
10.1.10 Lingrui
10.1.11 Sanofi
10.1.12 Qizheng
10.1.13 Endo
10.1.14 Huarun 999
10.1.15 Haw Par
10.1.16 Nichiban
10.1.17 Mentholatum Company
10.1.18 Laboratoires Genevrier
10.2 Transdermal Drug Delivery System Sales Date of Major Players (2017-2020e)
10.2.1 Hisamitsu
10.2.2 Mylan
10.2.3 GSK
10.2.4 Novartis
10.2.5 Teve (Actavis)
10.2.6 Johnson & Johnson
10.2.7 Lohmann
10.2.8 Teikoku Seiyaku
10.2.9 Bayer
10.2.10 Lingrui
10.2.11 Sanofi
10.2.12 Qizheng
10.2.13 Endo
10.2.14 Huarun 999
10.2.15 Haw Par
10.2.16 Nichiban
10.2.17 Mentholatum Company
10.2.18 Laboratoires Genevrier
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Transdermal Drug Delivery System Product Type Overview
2.Table Transdermal Drug Delivery System Product Type Market Share List
3.Table Transdermal Drug Delivery System Product Type of Major Players
4.Table Brief Introduction of Hisamitsu
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of GSK
7.Table Brief Introduction of Novartis
8.Table Brief Introduction of Teve (Actavis)
9.Table Brief Introduction of Johnson & Johnson
10.Table Brief Introduction of Lohmann
11.Table Brief Introduction of Teikoku Seiyaku
12.Table Brief Introduction of Bayer
13.Table Brief Introduction of Lingrui
14.Table Brief Introduction of Sanofi
15.Table Brief Introduction of Qizheng
16.Table Brief Introduction of Endo
17.Table Brief Introduction of Huarun 999
18.Table Brief Introduction of Haw Par
19.Table Brief Introduction of Nichiban
20.Table Brief Introduction of Mentholatum Company
21.Table Brief Introduction of Laboratoires Genevrier
22.Table Products & Services of Hisamitsu
23.Table Products & Services of Mylan
24.Table Products & Services of GSK
25.Table Products & Services of Novartis
26.Table Products & Services of Teve (Actavis)
27.Table Products & Services of Johnson & Johnson
28.Table Products & Services of Lohmann
29.Table Products & Services of Teikoku Seiyaku
30.Table Products & Services of Bayer
31.Table Products & Services of Lingrui
32.Table Products & Services of Sanofi
33.Table Products & Services of Qizheng
34.Table Products & Services of Endo
35.Table Products & Services of Huarun 999
36.Table Products & Services of Haw Par
37.Table Products & Services of Nichiban
38.Table Products & Services of Mentholatum Company
39.Table Products & Services of Laboratoires Genevrier
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
